116 related articles for article (PubMed ID: 16373996)
21. Assessment of the potential role of active vitamin D treatment in telomere length: a case-control study in hemodialysis patients.
Borras M; Panizo S; Sarró F; Valdivielso JM; Fernandez E
Clin Ther; 2012 Apr; 34(4):849-56. PubMed ID: 22417715
[TBL] [Abstract][Full Text] [Related]
22. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
Wu CC; Chen JS; Wu WM; Liao TN; Chu P; Lin SH; Chuang CH; Lin YF
Nephrol Dial Transplant; 2005 Jun; 20(6):1134-9. PubMed ID: 15814542
[TBL] [Abstract][Full Text] [Related]
23. Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease--a follow-up study.
Ignacy W; Chudek J; Adamczak M; Funahashi T; Matsuzawa Y; Kokot F; Wiecek A
Nephron Clin Pract; 2005; 101(1):c18-24. PubMed ID: 15886491
[TBL] [Abstract][Full Text] [Related]
24. The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients.
Valentini J; Grotto D; Paniz C; Roehrs M; Burg G; Garcia SC
Biomed Pharmacother; 2008; 62(6):378-82. PubMed ID: 18166291
[TBL] [Abstract][Full Text] [Related]
25. Acute effects of haemodialysis on biochemical modulators of endothelial function.
Hewitson CL; Whiting MJ; Barbara JA; Mangoni AA
J Intern Med; 2007 Nov; 262(5):571-80. PubMed ID: 17949366
[TBL] [Abstract][Full Text] [Related]
26. Association of plasma adiponectin levels with oxidative stress in hemodialysis patients.
Lim PS; Chen SL; Wu MY; Hu CY; Wu TK
Blood Purif; 2007; 25(4):362-9. PubMed ID: 17709916
[TBL] [Abstract][Full Text] [Related]
27. Carbonyl stress in chronic renal failure: the effect of haemodialysis.
Dursun E; Dursun B; Süleymanlar G; Ozben T
Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036
[TBL] [Abstract][Full Text] [Related]
28. Telomere length, oxidative stress, and antioxidant status in elderly men in Zutphen and Crete.
de Vos-Houben JM; Ottenheim NR; Kafatos A; Buijsse B; Hageman GJ; Kromhout D; Giltay EJ
Mech Ageing Dev; 2012 Jun; 133(6):373-7. PubMed ID: 22561920
[TBL] [Abstract][Full Text] [Related]
29. Correlates of habitual physical activity in chronic haemodialysis patients.
Zamojska S; Szklarek M; Niewodniczy M; Nowicki M
Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
[TBL] [Abstract][Full Text] [Related]
30. Telomere length assessment: biomarker of chronic oxidative stress?
Houben JM; Moonen HJ; van Schooten FJ; Hageman GJ
Free Radic Biol Med; 2008 Feb; 44(3):235-46. PubMed ID: 18021748
[TBL] [Abstract][Full Text] [Related]
31. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of oxidative stress before and after haemodialysis in chronic renal failure.
Chugh SN; Jain S; Agrawal N; Sharma A
J Assoc Physicians India; 2000 Oct; 48(10):981-4. PubMed ID: 11200923
[TBL] [Abstract][Full Text] [Related]
33. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
Hultqvist M; Hegbrant J; Nilsson-Thorell C; Lindholm T; Nilsson P; Lindén T; Hultqvist-Bengtsson U
Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
[TBL] [Abstract][Full Text] [Related]
34. Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C.
Sekoguchi S; Nakajima T; Moriguchi M; Jo M; Nishikawa T; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Tani Y; Okanoue T
J Gastroenterol Hepatol; 2007 Feb; 22(2):182-90. PubMed ID: 17295869
[TBL] [Abstract][Full Text] [Related]
35. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
[TBL] [Abstract][Full Text] [Related]
36. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
37. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
Tarng DC; Huang TP; Wei YH; Liu TY; Chen HW; Wen Chen T; Yang WC
Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress and ferritin levels in haemodialysis patients.
Senol E; Ersoy A; Erdinc S; Sarandol E; Yurtkuran M
Nephrol Dial Transplant; 2008 Feb; 23(2):665-72. PubMed ID: 18039638
[TBL] [Abstract][Full Text] [Related]
39. The effect of different dialysis membranes on oxidative stress and selenium status.
Yavuz O; Bicik Z; Cinar Y; Guney Y; Guler S
Clin Chim Acta; 2004 Aug; 346(2):153-60. PubMed ID: 15256316
[TBL] [Abstract][Full Text] [Related]
40. Telomere Length in Peripheral Blood Mononuclear Cells of Patients on Chronic Hemodialysis Is Related With Telomerase Activity and Treatment Duration.
Stefanidis I; Voliotis G; Papanikolaou V; Chronopoulou I; Eleftheriadis T; Kowald A; Zintzaras E; Tsezou A
Artif Organs; 2015 Sep; 39(9):756-64. PubMed ID: 25894013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
